Meridian To Begin Validation Studies For Prime ECG 510(k) Submission
This article was originally published in The Gray Sheet
Executive Summary
Meridian Medical Technologies intends to begin U.S. clinical trials for its Prime ECG electrocardiac mapping system early in the fall in support of a 510(k) application expected to be filed next year, the firm reports.